Expanding access to Advanced Ultrasound
Endoscopic ultrasound (EUS) provides critical diagnostic and therapeutic capabilities for pancreatic, biliary, and GI conditions, but traditional technology limits access to these capabilities due to cost and capital requirements.
That’s Why EndoSound Takes a Different Approach
We created a system that converts existing endoscopes into a complete EUS system.
The EndoSound Vision System (EVS) delivers comparable imaging at a fraction of traditional system costs, enabling deployment across care settings where patients receive procedures.
Leadership & Expertise
Scott Aldrich, Jr.
Chief Executive Officer
Stephen Steinberg, MD
Founder & Chief Medical Officer
Scott Corbett
Founder & Chief Technology Officer
Josh Cohn
Chief Commercial Officer
Paul Henwood
Chief Operations Officer
Patrick Hurley, Ph.D.
Vice President of Marketing
Patrick Herriman
Director Quality Assurance
Sam Ishizaka
Director of Operations
Sunil Smith
Senior Quality Engineer
Peter Hoffman
Sr. Product Development Engineer
Jeremy Hammer
Product Development Manager
Development & Validation
- FDA Clearance
December 2023. - FDA Breakthrough Device Designation
Successful in man procedures: 900+ - Robust IP Portfolio
11 patents issued and 9 pending. - Innovation of the Year
AGA CGIT Shark Tank 2022 competition & ASGE Innovation of the Year 2022. - Transitional Pass Through (TPT)
status awarded starting July 1, 2024. - Uses Existing Reimbursement CPT Codes
with early commercial progress and milestones attained. - Significant market traction
with early commercial progress and milestones attained. - 510(k) Clearance for Biopsy Port Adapter
cleared October 2025.
Implement EUS in your practice
Contact your EndoSound sales representative for ordering information, pricing details, and implementation support.